{
    "nctId": "NCT04289532",
    "briefTitle": "Integrin \u03b16-targeted SPECT Imaging of Breast Cancer",
    "officialTitle": "First-in-human Pilot Study of an Integrin \u03b16-targeted Radiotracer for SPECT Imaging of Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 9,
    "primaryOutcomeMeasure": "Blood Clearance",
    "eligibilityCriteria": "Inclusion criteria:\n\n* Healthy volunteers.\n* Body mass index (BMI) at 19 to 25 \\[Body mass index = body weight (kg)/ height squared (m2)\\];\n* Clinical laboratory tests (heart, liver, kidney, blood) indicators are in the normal range or abnormalities without clinical significance;\n* Informed written consents were obtained from all 9 subjects before the procedure.\n* Patients in suspicion of breast cancer by mammography or ultrasonography, and being able to provide basic information.\n\nExclution Criteria:\n\n\u2022 The investigator judged that it is not suitable for clinical trials based on the overall situation of the volunteers and patients.",
    "sex": "ALL",
    "minimumAge": "25 Years",
    "stdAges": "ADULT"
}